ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 48 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,421,168 | +4.1% | 583,414 | +20.7% | 0.00% | – |
| Q2 2023 | $2,324,789 | -14.7% | 483,324 | -28.0% | 0.00% | – |
| Q1 2023 | $2,726,821 | -55.9% | 671,631 | -41.3% | 0.00% | – |
| Q4 2022 | $6,181,310 | -44.7% | 1,144,687 | +2.7% | 0.00% | – |
| Q3 2022 | $11,184,000 | -11.6% | 1,115,027 | -58.6% | 0.00% | – |
| Q2 2022 | $12,658,000 | -15.5% | 2,693,311 | -29.7% | 0.00% | – |
| Q1 2022 | $14,980,000 | -28.7% | 3,831,321 | +23.2% | 0.00% | -100.0% |
| Q4 2021 | $21,021,000 | -50.7% | 3,109,670 | +8.4% | 0.00% | 0.0% |
| Q3 2021 | $42,629,000 | – | 2,868,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |